Original Research
Published on 19 Nov 2025
CldU sensitizes BRCA2 reverse-mutated cells to PARP inhibitors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1626301
- 1,331 views
Original Research
Published on 19 Nov 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 17 Aug 2017
in Neurogenesis